Page 4 - Bryanm Thomas News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FCF earnings call for the period ending September 30, 2021.

Operator Good day, and thank you for standing by. Welcome to the First Commonwealth Financial Corporation's Second Quarter 2021 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. [Operator Instructions] I would now like to hand the conference over to your speaker today, Ryan Thomas, Vice President of Finance and Investor Relations. Please go ahead. Ryan M. Thomas -- Vice President / Finance and Investor Relations Thank you, Pasha, and good afternoon, everyone. Thank you for joining us today to discuss First Commonwealth Financial Co...

Operator Good day, and thank you for standing by. Welcome to the First Commonwealth Financial Corporation's First Quarter 2021 Earnings Conference Call. [Operator instructions] After the speakers' presentation, there will be a question-and-answer session. [Operator instructions] I would now like to hand the conference over to Ryan Thomas, Vice President, Finance and Investor Relations. Thank you. Please go ahead, sir. Ryan M. Thomas -- Vice President . Finance and Investor Relations Thank you, operator. And good afternoon, everyone. Thank you for joining us today to discuss First Commonwealt...

(1)  Core operating results are a non-GAAP measure used by management to measure performance in operating the business that management believes enhances investors' ability to better understand the underlying business performance and trends related to core business activities. A full reconciliation of non-GAAP financial measures can be found at the end of the financial statements which accompany this release. (2)  Reserve build/(release) represents the net change in the Company's allowance for credit losses (ACL) from the prior period.          Financial results Net income of $39.8 m...

Article content A Vancouver company is studying COVID-19 vaccine candidates that could be effective in controlling mutant strains now taking over the world. According to a press release, Eyam Vaccines and Immunotherapeutics has started preclinical studies on the “efficacy of unique COVID-19 vaccine candidates that target SARS-CoV-2 variants.” We apologize, but this video has failed to load. Try refreshing your browser, or Vancouver company in fight to identify COVID-19 variant-killing vaccine Back to video The study is part of a joint venture licensing agreement struck last November wit...